德展健康(000813.SZ):控股股東擬協議轉讓2.6%股份
格隆匯6月18日丨德展健康(000813.SZ)公佈,公司近日收到公司控股股東美林集團的通知,由於美林集團在申萬宏源的一筆股票質押合約已到期待購回,美林集團於2020年6月15日與申萬宏源(作為證券行業支持民企發展之申萬宏源-資管2號管理人)簽署了《股份轉讓協議》,對上述股票質押式回購交易採用協議轉讓方式進行處置,美林集團擬通過協議轉讓方式轉讓其持有的公司5835.4568萬股無限售流通股,佔公司股份總數的2.6%。
此次股份轉讓完成後,美林集團直接持有公司5.7364億股股份,通過凱世富樂9號間接持有公司6840.5836萬股股份,合計持有6.4205億股股份,佔公司總股本的28.64%;申萬宏源-資管2號將持有公司股份5835.4568萬股,佔公司總股本2.60%,上述股份均為無限售流通股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.